Yttrium Y-90 Epratuzumab Tetraxetan

**Semantic type:** Amino Acid, Peptide, or Protein|Pharmacologic Substance

**Definition:** A radioimmunotherapeutic humanized murine monoclonal antibody (LL2) directed against the CD22 pan-B-cell antigen and chelated to the radioisotope yttrium-90 (Y 90). Y 90 humanized monoclonal antibody LL2 binds to tumor cells expressing CD22, delivering a cytotoxic dose of beta radiation.

**Synonyms:** - Monoclonal antibody LL2, yttrium Y 90 - Y 90 Humanized Monoclonal Antibody LL2 - Y 90 MoAb LL2 - Y 90 monoclonal antibody LL2 - Y90 Humanized Epratuzumab Tetraxetan - YTTRIUM Y-90 EPRATUZUMAB TETRAXETAN - Yttrium Y 90 Humanized Epratuzumab Tetraxetan - Yttrium Y 90 Humanized Monoclonal Antibody LL2 - yttrium Y 90 MOAB LL2